
The authors of a study suggesting that a deep freeze might help reverse one of the curious complications of COVID-19 have put their paper on ice after determining that they lacked adequate ethics approval for the research.
“Whole-Body Cryotherapy as an Innovative Treatment for COVID 19-Induced Anosmia-Hyposmia: A Feasibility Study,” was written by a group in France led by Fabien D. Legrand, of the University of Reims. The article appeared online this January in the Journal of Integrative and Complementary Medicine.
The randomized study looked at the effect of cryotherapy in 45 people whose sense of smell had been disrupted by COVID. Two-thirds received either high- or low-dose cryotherapy – which Legrand’s team defined as exposure to “extremely low temperatures (−60°C to −110°C) in a double Cryoair chamber (MECOTEC, Pforzheim, Germany) for 3 min” – while a third were assigned to a control group.
According to the investigators, whose affiliations included the French Society of Whole-Body Cryotherapy — and who nonetheless registered their protocol in the Iranian Registry of Clinical Trials:
Continue reading Study of cryotherapy for COVID-19 anosmia fails the sniff test